Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer (Q46135004)
scientific article published on 21 June 2006
Language:
Current Data About Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer
(P31) (Q13442814)
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

(P50) (Q107013145)
(P1545) 1
(P1932) Bradley J Monk
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

(P304) 140-144
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

(P407) (Q1860)

(P433) 2
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

(P478) 102
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

(P577) Wednesday, June 21, 2006
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

(P921) (Q246181)

(Q413299)
(P887)

(Q172341)
(P887)

(P1433) (Q5625182)
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

(P1476) "Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer" (language: en)
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

(P2093) Ernest Han
(P1545) 2
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

Carol A Josephs-Cowan
(P1545) 3
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

Gordon Pugmire
(P1545) 4
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

Robert A Burger
(P1545) 5
(P248)
(P698) 16790264
(P813) Tuesday, December 19, 2017
(P854) http://europepmc.org/abstract/MED/16790264

(P2860) (Q29620739)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

(Q33348987)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

(Q36262349)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

(Q27860681)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

(Q36509678)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

(Q81420892)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

(Q46124385)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

(Q35125943)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

(Q45057186)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

(Q25938997)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

(Q40624513)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

(Q46666366)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.006
(P813) Thursday, January 7, 2021

other details
description scientific article published on 21 June 2006

External Links
(P356) 10.1016/J.YGYNO.2006.05.006
(P698) 16790264